Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental DisordersNicole M. Fisher(Vanderbilt University), Colleen M. Niswender(Vanderbilt University)Frontiers in Molecular NeuroscienceOctober 23, 201810.3389/fnmol.2018.00387Cited by 47SaveCiteExport RISWatch citationsRelated PapersA GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes|JCI Insight|2021|29